ArticleBiology2026
Caffeic Acid Mitigates L-Methionine-Induced Impairment of Hippocampal Neural Stem Cells Through Anti-Apoptotic Signaling in Adult Rats.
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Chronic administration of L-methionine (L-met) induces hyperhomocysteinemia, which triggers oxidative stress, impairs hippocampal neurogenesis and ultimately causes cognitive decline. Caffeic acid (CA) has been reported to exert neuroprotective effects through its antioxidant properties, attenuating oxidative damage in the brain, promoting hippocampal neurogenesis, and improving cognitive function. This study evaluated the neuroprotective efficacy of CA against L-met-mediated hyperhomocysteinemia and associated hippocampal neurotoxicity in a rat model. Twenty-four male Sprague-Dawley rats were randomly divided into four groups (n = 6/group): Vehicle, L-met (1.7 g/kg), CA (40 mg/kg), and CA + L-met. Treatments were administered orally once daily for 28 days. Immunofluorescence analysis revealed that CA effectively prevented L-met-induced depletion of nestin-positive cells. Structural assessments further confirmed that CA counteracted tissue atrophy, preserving the anatomical volumes of both the dentate gyrus (DG) and granule cell layer (GCL). Furthermore, CA attenuated the L-met-induced downregulation of the neurogenesis-related proteins nestin and Notch-1 in the hippocampus. Notably, CA also modulated apoptosis-related protein expression by reducing Bax and Caspase-3 levels while upregulating Bcl-2 expression. In conclusion, CA was associated with protection against L-met-induced alterations in hippocampal neurogenesis- and apoptosis-related protein expression, as well as preservation of hippocampal architecture, in this experimental model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.